Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Sep '11 Sep 30, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006
Revenue	0.39	0.32	-	-	0.33	0.29
Revenue Growth (YoY)	-	-	-	-	13.94%	-
Cost of Revenue	0.2	0.13	-	-	-	-
Gross Profit	0.2	0.19	-	-	0.33	0.29
Selling, General & Admin	2.05	1.8	-	-	0.33	0.29
Other Operating Expenses	0.05	0.05	0.69	-	-	-
Operating Expenses	2.14	1.89	0.69	-	0.33	0.29
Operating Income	-1.94	-1.7	-0.69	-	0.01	0
Interest Expense	-	-	-0.02	-	-	-
Interest & Investment Income	0	0	-	-	-	-
Other Non Operating Income (Expenses)	-0.02	-0.02	-	-	-	-
EBT Excluding Unusual Items	-1.95	-1.71	-0.71	-	0.01	0
Gain (Loss) on Sale of Investments	-0.3	-0.3	-0.01	-	-	-
Pretax Income	-2.32	-2.01	-0.72	-	0.01	0
Income Tax Expense	-	-	-	-	0	-
Earnings From Continuing Operations	-2.32	-2.01	-0.72	-	0	0
Earnings From Discontinued Operations	-	-	-	-0.01	-	-
Net Income	-2.32	-2.01	-0.72	-0.01	0	0
Net Income to Common	-2.32	-2.01	-0.72	-0.01	0	0
Net Income Growth	-	-	-	-	-1.24%	-
Shares Outstanding (Basic)	85	84	23	23	18	12
Shares Outstanding (Diluted)	85	84	23	23	18	12
Shares Change (YoY)	25.73%	269.77%	-	28.94%	46.33%	-
EPS (Basic)	-0.03	-0.02	-0.03	-0.00	0.00	0.00
EPS (Diluted)	-0.03	-0.02	-0.03	-0.00	0.00	0.00
EPS Growth	-	-	-	-	-32.69%	-
Free Cash Flow	-2.27	-2.27	-0.68	-0.01	0.01	0
Free Cash Flow Per Share	-0.03	-0.03	-0.03	-0.00	-	-
Gross Margin	49.76%	59.87%	-	-	100.00%	100.00%
Operating Margin	-494.69%	-536.72%	-	-	2.02%	1.71%
Profit Margin	-591.46%	-636.18%	-	-	1.48%	1.71%
Free Cash Flow Margin	-578.79%	-718.33%	-	-	1.52%	0.42%
EBITDA	-1.9	-1.67	-0.69	-	0.01	0.01
EBITDA Margin	-	-	-	-	2.89%	2.20%
D&A For EBITDA	0.04	0.03	0	0	0	0
EBIT	-1.94	-1.7	-0.69	-	0.01	0
EBIT Margin	-	-	-	-	2.02%	1.71%
Effective Tax Rate	-	-	-	-	26.76%	-
Revenue as Reported	-	-	-	-	0.33	0.29

Updated Nov 10, 2011. Source: S&P Global Market Intelligence. Standard template. Financial Sources.